Share Price and Basic Stock Data
Last Updated: January 9, 2026, 2:49 am
| PEG Ratio | -2.03 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Tata Chemicals Ltd operates in the chemicals sector, particularly focusing on inorganic chemicals such as caustic soda and soda ash. As of the latest reporting, the company’s stock price stood at ₹784, with a market capitalization of ₹19,968 Cr. The company reported a total sales figure of ₹16,789 Cr for the fiscal year ending March 2023, a notable increase from ₹12,622 Cr in FY 2022. However, the trailing twelve months (TTM) revenue declined to ₹14,695 Cr, indicating potential challenges in sustaining growth in the current environment. Quarterly sales data reflects a decreasing trend, with Q2 FY 2024 sales at ₹3,998 Cr, down from ₹4,239 Cr in Q2 FY 2023. This decline in revenue could be attributed to various factors, including market conditions and operational challenges. The overall sales performance highlights a mixed picture, suggesting the need for strategic adjustments to bolster revenue generation.
Profitability and Efficiency Metrics
The profitability of Tata Chemicals has exhibited volatility, with the company recording an operating profit margin (OPM) of 14% as of the latest reporting. This figure reflects a decline from the previous year’s OPM of 23% in FY 2023. The net profit for the fiscal year ending March 2024 was reported at ₹387 Cr, which is significantly lower than the ₹2,434 Cr net profit recorded in FY 2023. The company’s interest coverage ratio (ICR) stood at 3.87x, indicating that the firm can comfortably cover its interest obligations. However, the return on equity (ROE) remained low at 1.20%, suggesting inefficiencies in generating returns for shareholders. The cash conversion cycle was reported at 53 days, which is relatively healthy, yet the declining OPM and net profit raise concerns about operational efficiency. The company must focus on cost management and operational efficiencies to improve profitability.
Balance Sheet Strength and Financial Ratios
Tata Chemicals reported total reserves of ₹22,103 Cr, alongside borrowings of ₹7,495 Cr, indicating a solid capital structure. The company’s total liabilities stood at ₹37,750 Cr, which reflects a manageable debt level with a total debt-to-equity ratio of 0.29. The book value per share (including revaluation reserves) was recorded at ₹846.82, suggesting a reasonable valuation compared to the current price-to-book value (P/BV) ratio of 1.02x. The company’s current ratio was reported at 1.09, indicating sufficient liquidity to meet short-term obligations. However, the declining return on capital employed (ROCE) at 4% raises concerns about the effective utilization of capital. The interest coverage ratio of 3.87x is satisfactory, but the company must continue to monitor its leverage to maintain financial stability in a fluctuating market environment.
Shareholding Pattern and Investor Confidence
The shareholding structure of Tata Chemicals reveals a diverse ownership profile, with promoters holding 37.98% of the equity, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 13.73% and 22.17%, respectively. Public ownership accounts for 26.07%, with a total of 6,50,693 shareholders as of the latest report. The stability in promoter holding suggests confidence in the company’s long-term strategy. However, the slight decline in FII ownership from 14.43% in December 2022 to 13.73% in September 2025 could indicate a cautious outlook among foreign investors. The DII shareholding has remained relatively stable, which may reflect a more favorable view among domestic investors regarding the company’s potential. Overall, the diverse shareholder base could provide stability, but fluctuations in institutional holdings warrant close observation.
Outlook, Risks, and Final Insight
The outlook for Tata Chemicals is characterized by both opportunities and risks. The company’s strong reserves and manageable debt levels position it well for potential growth initiatives. However, declining profitability metrics and fluctuating sales present significant challenges that need to be addressed. Potential risks include market volatility, increased competition in the chemicals sector, and the impact of global economic conditions on raw material costs. Strategic initiatives aimed at enhancing operational efficiency and expanding product offerings could bolster revenue and profitability. In scenarios where the company successfully implements cost control measures and navigates market challenges, it could regain momentum. Conversely, failure to address these issues may result in continued pressure on margins and investor sentiment. Overall, Tata Chemicals must leverage its strengths while mitigating risks to ensure sustainable growth moving forward.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 27.0 Cr. | 58.6 | 69.0/37.5 | 2,696 | 11.6 | 0.00 % | 0.48 % | 13.7 % | 10.0 |
| Standard Industries Ltd | 101 Cr. | 15.8 | 28.4/14.9 | 20.4 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 3,577 Cr. | 487 | 753/483 | 23,844 | 759 | 3.24 % | 0.34 % | 1.13 % | 10.0 |
| GHCL Ltd | 5,117 Cr. | 557 | 779/511 | 8.98 | 378 | 2.16 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 19,462 Cr. | 764 | 1,027/742 | 59.7 | 877 | 1.44 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 5,778.20 Cr | 386.90 | 5,330.24 | 389.00 | 1.19% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,239 | 4,148 | 4,407 | 4,218 | 3,998 | 3,730 | 3,475 | 3,789 | 3,999 | 3,590 | 3,509 | 3,719 | 3,877 |
| Expenses | 3,319 | 3,317 | 3,442 | 3,175 | 3,191 | 3,188 | 3,032 | 3,215 | 3,381 | 3,156 | 3,182 | 3,070 | 3,340 |
| Operating Profit | 920 | 831 | 965 | 1,043 | 807 | 542 | 443 | 574 | 618 | 434 | 327 | 649 | 537 |
| OPM % | 22% | 20% | 22% | 25% | 20% | 15% | 13% | 15% | 15% | 12% | 9% | 17% | 14% |
| Other Income | 102 | 30 | 86 | 67 | 187 | 98 | -861 | 116 | 152 | -10 | 29 | 138 | 128 |
| Interest | 86 | 107 | 133 | 123 | 145 | 132 | 130 | 133 | 145 | 148 | 137 | 147 | 144 |
| Depreciation | 218 | 227 | 234 | 229 | 234 | 246 | 271 | 273 | 277 | 280 | 293 | 280 | 285 |
| Profit before tax | 718 | 527 | 684 | 758 | 615 | 262 | -819 | 284 | 348 | -4 | -74 | 360 | 236 |
| Tax % | 5% | 19% | -1% | 23% | 20% | 26% | 3% | 33% | 23% | 425% | -34% | 12% | 35% |
| Net Profit | 680 | 425 | 692 | 587 | 495 | 194 | -841 | 190 | 267 | -21 | -49 | 316 | 154 |
| EPS in Rs | 24.65 | 15.35 | 27.83 | 20.88 | 16.80 | 6.20 | -33.36 | 5.89 | 7.61 | -2.08 | -2.20 | 9.89 | 3.02 |
Last Updated: January 1, 2026, 7:04 pm
Below is a detailed analysis of the quarterly data for Tata Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,877.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,719.00 Cr. (Jun 2025) to 3,877.00 Cr., marking an increase of 158.00 Cr..
- For Expenses, as of Sep 2025, the value is 3,340.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,070.00 Cr. (Jun 2025) to 3,340.00 Cr., marking an increase of 270.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 537.00 Cr.. The value appears to be declining and may need further review. It has decreased from 649.00 Cr. (Jun 2025) to 537.00 Cr., marking a decrease of 112.00 Cr..
- For OPM %, as of Sep 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Jun 2025) to 14.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 128.00 Cr.. The value appears to be declining and may need further review. It has decreased from 138.00 Cr. (Jun 2025) to 128.00 Cr., marking a decrease of 10.00 Cr..
- For Interest, as of Sep 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 147.00 Cr. (Jun 2025) to 144.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 285.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 280.00 Cr. (Jun 2025) to 285.00 Cr., marking an increase of 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 236.00 Cr.. The value appears to be declining and may need further review. It has decreased from 360.00 Cr. (Jun 2025) to 236.00 Cr., marking a decrease of 124.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 12.00% (Jun 2025) to 35.00%, marking an increase of 23.00%.
- For Net Profit, as of Sep 2025, the value is 154.00 Cr.. The value appears to be declining and may need further review. It has decreased from 316.00 Cr. (Jun 2025) to 154.00 Cr., marking a decrease of 162.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.02. The value appears to be declining and may need further review. It has decreased from 9.89 (Jun 2025) to 3.02, marking a decrease of 6.87.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15,885 | 17,204 | 14,873 | 10,346 | 10,270 | 10,337 | 10,357 | 10,200 | 12,622 | 16,789 | 15,421 | 14,887 | 14,695 |
| Expenses | 15,200 | 15,305 | 12,777 | 8,249 | 6,926 | 8,538 | 8,411 | 8,693 | 10,317 | 12,969 | 12,574 | 12,934 | 12,748 |
| Operating Profit | 686 | 1,900 | 2,096 | 2,097 | 3,344 | 1,799 | 1,945 | 1,506 | 2,305 | 3,820 | 2,847 | 1,953 | 1,947 |
| OPM % | 4% | 11% | 14% | 20% | 33% | 17% | 19% | 15% | 18% | 23% | 18% | 13% | 13% |
| Other Income | -154 | 183 | 210 | 293 | 262 | 785 | 6,480 | 254 | 486 | 218 | -521 | 287 | 285 |
| Interest | 579 | 461 | 525 | 297 | 326 | 354 | 342 | 367 | 303 | 406 | 530 | 563 | 576 |
| Depreciation | 471 | 463 | 526 | 512 | 518 | 568 | 666 | 759 | 806 | 892 | 980 | 1,123 | 1,138 |
| Profit before tax | -519 | 1,159 | 1,255 | 1,580 | 2,763 | 1,661 | 7,416 | 634 | 1,682 | 2,740 | 816 | 554 | 518 |
| Tax % | 56% | 30% | 20% | 22% | 2% | 17% | 3% | 31% | 16% | 11% | 47% | 30% | |
| Net Profit | -811 | 802 | 1,006 | 1,234 | 2,702 | 1,387 | 7,228 | 436 | 1,405 | 2,434 | 435 | 387 | 400 |
| EPS in Rs | -40.50 | 23.41 | 30.24 | 38.98 | 95.49 | 45.37 | 274.97 | 10.06 | 49.37 | 90.93 | 10.52 | 9.22 | 8.63 |
| Dividend Payout % | -25% | 53% | 33% | 28% | 23% | 28% | 4% | 99% | 25% | 19% | 143% | 119% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 198.89% | 25.44% | 22.66% | 118.96% | -48.67% | 421.12% | -93.97% | 222.25% | 73.24% | -82.13% | -11.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | -173.45% | -2.77% | 96.30% | -167.63% | 469.79% | -515.09% | 316.22% | -149.01% | -155.37% | 71.09% |
Tata Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 8% |
| 3 Years: | 6% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -48% |
| 3 Years: | -40% |
| TTM: | -45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 25% |
| 3 Years: | -6% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 4:00 am
Balance Sheet
Last Updated: December 4, 2025, 1:14 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 |
| Reserves | 5,311 | 5,297 | 6,600 | 7,653 | 10,847 | 12,086 | 12,643 | 14,035 | 17,998 | 19,466 | 21,986 | 21,339 | 22,103 |
| Borrowings | 8,393 | 8,379 | 9,090 | 7,072 | 6,108 | 6,130 | 7,702 | 6,933 | 7,024 | 6,296 | 5,563 | 7,072 | 7,495 |
| Other Liabilities | 6,127 | 6,872 | 8,402 | 8,607 | 8,648 | 8,398 | 7,073 | 7,115 | 8,566 | 8,923 | 8,907 | 9,084 | 9,002 |
| Total Liabilities | 20,086 | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,750 | 38,855 |
| Fixed Assets | 11,007 | 11,359 | 13,431 | 12,644 | 12,787 | 13,551 | 15,356 | 15,261 | 16,044 | 17,092 | 17,861 | 19,600 | 20,171 |
| CWIP | 468 | 189 | 350 | 333 | 409 | 774 | 835 | 1,094 | 1,668 | 2,410 | 2,217 | 1,913 | 2,099 |
| Investments | 441 | 443 | 2,188 | 2,787 | 2,840 | 5,615 | 4,285 | 5,816 | 7,683 | 7,448 | 9,739 | 9,144 | 9,555 |
| Other Assets | 8,171 | 8,811 | 8,377 | 7,822 | 9,822 | 6,929 | 7,198 | 6,167 | 8,448 | 7,990 | 6,894 | 7,093 | 7,030 |
| Total Assets | 20,086 | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,750 | 38,855 |
Below is a detailed analysis of the balance sheet data for Tata Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 255.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 255.00 Cr..
- For Reserves, as of Sep 2025, the value is 22,103.00 Cr.. The value appears strong and on an upward trend. It has increased from 21,339.00 Cr. (Mar 2025) to 22,103.00 Cr., marking an increase of 764.00 Cr..
- For Borrowings, as of Sep 2025, the value is 7,495.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7,072.00 Cr. (Mar 2025) to 7,495.00 Cr., marking an increase of 423.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9,002.00 Cr.. The value appears to be improving (decreasing). It has decreased from 9,084.00 Cr. (Mar 2025) to 9,002.00 Cr., marking a decrease of 82.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 38,855.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37,750.00 Cr. (Mar 2025) to 38,855.00 Cr., marking an increase of 1,105.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 20,171.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,600.00 Cr. (Mar 2025) to 20,171.00 Cr., marking an increase of 571.00 Cr..
- For CWIP, as of Sep 2025, the value is 2,099.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,913.00 Cr. (Mar 2025) to 2,099.00 Cr., marking an increase of 186.00 Cr..
- For Investments, as of Sep 2025, the value is 9,555.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,144.00 Cr. (Mar 2025) to 9,555.00 Cr., marking an increase of 411.00 Cr..
- For Other Assets, as of Sep 2025, the value is 7,030.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,093.00 Cr. (Mar 2025) to 7,030.00 Cr., marking a decrease of 63.00 Cr..
- For Total Assets, as of Sep 2025, the value is 38,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 37,750.00 Cr. (Mar 2025) to 38,855.00 Cr., marking an increase of 1,105.00 Cr..
Notably, the Reserves (22,103.00 Cr.) exceed the Borrowings (7,495.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 678.00 | -7.00 | -7.00 | -5.00 | -3.00 | -5.00 | -6.00 | -5.00 | -5.00 | -3.00 | -3.00 | -6.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 73 | 88 | 74 | 46 | 51 | 56 | 50 | 56 | 57 | 45 | 47 |
| Inventory Days | 96 | 137 | 119 | 244 | 304 | 315 | 347 | 257 | 318 | 282 | 341 | 324 |
| Days Payable | 119 | 138 | 99 | 232 | 307 | 269 | 302 | 256 | 338 | 289 | 320 | 318 |
| Cash Conversion Cycle | 52 | 72 | 107 | 86 | 43 | 97 | 100 | 51 | 35 | 50 | 66 | 53 |
| Working Capital Days | 11 | -4 | 31 | -4 | 27 | -2 | -102 | 27 | -29 | 29 | -22 | -21 |
| ROCE % | 3% | 11% | 11% | 10% | 16% | 9% | 36% | 4% | 8% | 12% | 8% | 4% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Flexicap Fund | 3,750,000 | 0.53 | 300.15 | N/A | N/A | N/A |
| ICICI Prudential India Opportunities Fund | 2,879,270 | 0.68 | 230.46 | N/A | N/A | N/A |
| ICICI Prudential Value Fund | 2,843,828 | 0.38 | 227.62 | 2,792,806 | 2025-12-15 00:52:54 | 1.83% |
| ICICI Prudential Multicap Fund | 2,584,831 | 1.28 | 206.89 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 2,320,406 | 2.2 | 185.73 | 2,300,000 | 2025-12-15 00:52:54 | 0.89% |
| Kotak Large & Midcap Fund | 2,064,884 | 0.55 | 165.27 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 1,137,376 | 0.12 | 91.04 | N/A | N/A | N/A |
| Tata Ethical Fund | 652,838 | 1.39 | 52.25 | N/A | N/A | N/A |
| ICICI Prudential Dividend Yield Equity Fund | 625,881 | 0.79 | 50.1 | N/A | N/A | N/A |
| Tata Mid Cap Fund | 615,450 | 0.91 | 49.26 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 9.23 | 10.52 | 90.95 | 49.37 | 10.06 |
| Diluted EPS (Rs.) | 9.23 | 10.52 | 90.95 | 49.37 | 10.06 |
| Cash EPS (Rs.) | 53.18 | 52.82 | 130.43 | 77.91 | 45.91 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 846.82 | 906.43 | 809.49 | 751.80 | 594.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 846.82 | 906.43 | 809.49 | 751.80 | 594.25 |
| Revenue From Operations / Share (Rs.) | 583.80 | 604.75 | 658.39 | 495.33 | 400.27 |
| PBDIT / Share (Rs.) | 85.41 | 122.86 | 158.43 | 100.49 | 68.09 |
| PBIT / Share (Rs.) | 41.37 | 84.43 | 123.45 | 68.85 | 38.29 |
| PBT / Share (Rs.) | 14.39 | 29.88 | 107.45 | 56.53 | 23.87 |
| Net Profit / Share (Rs.) | 9.14 | 14.39 | 95.45 | 46.27 | 16.11 |
| NP After MI And SOA / Share (Rs.) | 9.21 | 10.51 | 90.86 | 49.35 | 10.06 |
| PBDIT Margin (%) | 14.63 | 20.31 | 24.06 | 20.28 | 17.01 |
| PBIT Margin (%) | 7.08 | 13.96 | 18.75 | 13.90 | 9.56 |
| PBT Margin (%) | 2.46 | 4.94 | 16.32 | 11.41 | 5.96 |
| Net Profit Margin (%) | 1.56 | 2.37 | 14.49 | 9.34 | 4.02 |
| NP After MI And SOA Margin (%) | 1.57 | 1.73 | 13.80 | 9.96 | 2.51 |
| Return on Networth / Equity (%) | 1.08 | 1.20 | 11.74 | 6.88 | 1.79 |
| Return on Capital Employeed (%) | 3.33 | 7.01 | 10.43 | 6.55 | 4.08 |
| Return On Assets (%) | 0.62 | 0.72 | 6.60 | 3.71 | 0.90 |
| Long Term Debt / Equity (X) | 0.19 | 0.13 | 0.28 | 0.20 | 0.36 |
| Total Debt / Equity (X) | 0.29 | 0.22 | 0.30 | 0.37 | 0.38 |
| Asset Turnover Ratio (%) | 0.39 | 0.42 | 0.48 | 0.40 | 0.14 |
| Current Ratio (X) | 1.09 | 1.05 | 1.66 | 1.23 | 1.49 |
| Quick Ratio (X) | 0.67 | 0.63 | 1.15 | 0.90 | 1.11 |
| Inventory Turnover Ratio (X) | 1.01 | 1.07 | 1.22 | 1.22 | 0.50 |
| Dividend Payout Ratio (NP) (%) | 162.55 | 166.41 | 13.72 | 20.25 | 109.30 |
| Dividend Payout Ratio (CP) (%) | 28.12 | 35.73 | 9.90 | 12.34 | 27.59 |
| Earning Retention Ratio (%) | -62.55 | -66.41 | 86.28 | 79.75 | -9.30 |
| Cash Earning Retention Ratio (%) | 71.88 | 64.27 | 90.10 | 87.66 | 72.41 |
| Interest Coverage Ratio (X) | 3.87 | 5.91 | 9.95 | 8.46 | 4.72 |
| Interest Coverage Ratio (Post Tax) (X) | 1.58 | 3.34 | 7.04 | 4.91 | 2.12 |
| Enterprise Value (Cr.) | 28656.05 | 32847.30 | 31130.10 | 31228.96 | 24062.00 |
| EV / Net Operating Revenue (X) | 1.92 | 2.13 | 1.85 | 2.47 | 2.36 |
| EV / EBITDA (X) | 13.16 | 10.48 | 7.71 | 12.20 | 13.87 |
| MarketCap / Net Operating Revenue (X) | 1.48 | 1.79 | 1.48 | 1.97 | 1.88 |
| Retention Ratios (%) | -62.55 | -66.41 | 86.27 | 79.74 | -9.30 |
| Price / BV (X) | 1.02 | 1.24 | 1.26 | 1.36 | 1.34 |
| Price / Net Operating Revenue (X) | 1.48 | 1.79 | 1.48 | 1.97 | 1.88 |
| EarningsYield | 0.01 | 0.01 | 0.09 | 0.05 | 0.01 |
After reviewing the key financial ratios for Tata Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.23. This value is within the healthy range. It has decreased from 10.52 (Mar 24) to 9.23, marking a decrease of 1.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.23. This value is within the healthy range. It has decreased from 10.52 (Mar 24) to 9.23, marking a decrease of 1.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 53.18. This value is within the healthy range. It has increased from 52.82 (Mar 24) to 53.18, marking an increase of 0.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 846.82. It has decreased from 906.43 (Mar 24) to 846.82, marking a decrease of 59.61.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 846.82. It has decreased from 906.43 (Mar 24) to 846.82, marking a decrease of 59.61.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 583.80. It has decreased from 604.75 (Mar 24) to 583.80, marking a decrease of 20.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 85.41. This value is within the healthy range. It has decreased from 122.86 (Mar 24) to 85.41, marking a decrease of 37.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 41.37. This value is within the healthy range. It has decreased from 84.43 (Mar 24) to 41.37, marking a decrease of 43.06.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.39. This value is within the healthy range. It has decreased from 29.88 (Mar 24) to 14.39, marking a decrease of 15.49.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.14. This value is within the healthy range. It has decreased from 14.39 (Mar 24) to 9.14, marking a decrease of 5.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.21. This value is within the healthy range. It has decreased from 10.51 (Mar 24) to 9.21, marking a decrease of 1.30.
- For PBDIT Margin (%), as of Mar 25, the value is 14.63. This value is within the healthy range. It has decreased from 20.31 (Mar 24) to 14.63, marking a decrease of 5.68.
- For PBIT Margin (%), as of Mar 25, the value is 7.08. This value is below the healthy minimum of 10. It has decreased from 13.96 (Mar 24) to 7.08, marking a decrease of 6.88.
- For PBT Margin (%), as of Mar 25, the value is 2.46. This value is below the healthy minimum of 10. It has decreased from 4.94 (Mar 24) to 2.46, marking a decrease of 2.48.
- For Net Profit Margin (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 2.37 (Mar 24) to 1.56, marking a decrease of 0.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.57. This value is below the healthy minimum of 8. It has decreased from 1.73 (Mar 24) to 1.57, marking a decrease of 0.16.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 15. It has decreased from 1.20 (Mar 24) to 1.08, marking a decrease of 0.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.33. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 3.33, marking a decrease of 3.68.
- For Return On Assets (%), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 5. It has decreased from 0.72 (Mar 24) to 0.62, marking a decrease of 0.10.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.13 (Mar 24) to 0.19, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.29, marking an increase of 0.07.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.39. It has decreased from 0.42 (Mar 24) to 0.39, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 1.5. It has increased from 1.05 (Mar 24) to 1.09, marking an increase of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.67, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 4. It has decreased from 1.07 (Mar 24) to 1.01, marking a decrease of 0.06.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 162.55. This value exceeds the healthy maximum of 50. It has decreased from 166.41 (Mar 24) to 162.55, marking a decrease of 3.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 28.12. This value is within the healthy range. It has decreased from 35.73 (Mar 24) to 28.12, marking a decrease of 7.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is -62.55. This value is below the healthy minimum of 40. It has increased from -66.41 (Mar 24) to -62.55, marking an increase of 3.86.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 71.88. This value exceeds the healthy maximum of 70. It has increased from 64.27 (Mar 24) to 71.88, marking an increase of 7.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.87. This value is within the healthy range. It has decreased from 5.91 (Mar 24) to 3.87, marking a decrease of 2.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.58. This value is below the healthy minimum of 3. It has decreased from 3.34 (Mar 24) to 1.58, marking a decrease of 1.76.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28,656.05. It has decreased from 32,847.30 (Mar 24) to 28,656.05, marking a decrease of 4,191.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.13 (Mar 24) to 1.92, marking a decrease of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 13.16. This value is within the healthy range. It has increased from 10.48 (Mar 24) to 13.16, marking an increase of 2.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 1.79 (Mar 24) to 1.48, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is -62.55. This value is below the healthy minimum of 30. It has increased from -66.41 (Mar 24) to -62.55, marking an increase of 3.86.
- For Price / BV (X), as of Mar 25, the value is 1.02. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.02, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 1.79 (Mar 24) to 1.48, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tata Chemicals Ltd:
- Net Profit Margin: 1.56%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.33% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.08% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.58
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 59.7 (Industry average Stock P/E: 5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.29
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.56%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | Bombay House, 24, Homi Mody Street, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S Padmanabhan | Chairman |
| Mr. R Mukundan | Managing Director & CEO |
| Mr. Modan Saha | Director |
| Mrs. Padmini Khare Kaicker | Independent Director |
| Mr. Rajiv Dube | Independent Director |
| Dr. C V Natraj | Independent Director |
| Mr. K B S Anand | Independent Director |
FAQ
What is the intrinsic value of Tata Chemicals Ltd?
Tata Chemicals Ltd's intrinsic value (as of 08 January 2026) is ₹509.86 which is 33.26% lower the current market price of ₹764.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹19,462 Cr. market cap, FY2025-2026 high/low of ₹1,027/742, reserves of ₹22,103 Cr, and liabilities of ₹38,855 Cr.
What is the Market Cap of Tata Chemicals Ltd?
The Market Cap of Tata Chemicals Ltd is 19,462 Cr..
What is the current Stock Price of Tata Chemicals Ltd as on 08 January 2026?
The current stock price of Tata Chemicals Ltd as on 08 January 2026 is ₹764.
What is the High / Low of Tata Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tata Chemicals Ltd stocks is ₹1,027/742.
What is the Stock P/E of Tata Chemicals Ltd?
The Stock P/E of Tata Chemicals Ltd is 59.7.
What is the Book Value of Tata Chemicals Ltd?
The Book Value of Tata Chemicals Ltd is 877.
What is the Dividend Yield of Tata Chemicals Ltd?
The Dividend Yield of Tata Chemicals Ltd is 1.44 %.
What is the ROCE of Tata Chemicals Ltd?
The ROCE of Tata Chemicals Ltd is 3.96 %.
What is the ROE of Tata Chemicals Ltd?
The ROE of Tata Chemicals Ltd is 1.20 %.
What is the Face Value of Tata Chemicals Ltd?
The Face Value of Tata Chemicals Ltd is 10.0.